Anti-MT antibodies as novel therapy for acetaminophen-induced liver injury.

Crosstalk between angiogenesis and macrophages in pediatric non-alcoholic fatty liver disease

MASLD, alcohol and bariatric surgery

Maternal insulin resistance: fueling offspring fatty liver via metabolic dysregulation?

PPAR and ERR as dual targets for combinational treatment of steatotic liver disease-associated cancer

The adaptive hypoxia system of the prolyl hydroxylases (PHD) in the pathophysiology of Non-Alcoholic Steatohepatitis (NASH)

The role of 'endoplasmic reticulum (ER) stress' and the 'integrated stress response' in the pathogenesis of hepatic encephalopathy (HE): Exploring the therapeutic potential of ER stress modulation in HE.

The role of prolyl hydroxylases in endothelial dysfunction in the pathogenesis of Non-Alcoholic Steatohepatitis

The role of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in the pathophysiology of the hepatopulmonary syndrome

A study of the therapeutic potential of PPARa-ERRa ligand combinations in non-alcoholic fatty liver disease

Functional analysis of transcription factors involved in cell cycle regulation of plants, by a new generic tool based on tandem affinity purification and deep sequencing.

Role of angiogenesis and angiogenetic growth factors (VEGF, PLGF) in portal hypertension and fibrosis formation in animal models of cirrhosis, steatosis and portal hypertension.

Role of ER stress in the angiogenesis associated with liver cirrhosis and portal hypertension

The Seahorse XFe96 analyzer to decipher cellular bioenergetics and mitochondrial dysfunction after exposure to food and environmental stressors.

The study of the therapeutic potential of PPARa-ERRa ligand combinations in non-alcoholic fatty liver disease

Towards Personalized Treatment for Pediatric Obesity through Mechanistically Confirmed Source-Driven Metabolome Predictions